These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Indications, technique, and outcome of therapeutic apheresis in European pediatric nephrology units. Paglialonga F; Schmitt CP; Shroff R; Vondrak K; Aufricht C; Watson AR; Ariceta G; Fischbach M; Klaus G; Holtta T; Bakkaloglu SA; Zurowska A; Jankauskiene A; Vande Walle J; Schaefer B; Wright E; Connell R; Edefonti A Pediatr Nephrol; 2015 Jan; 30(1):103-11. PubMed ID: 25135618 [TBL] [Abstract][Full Text] [Related]
8. A prospective study comparing tryptophan immunoadsorption with therapeutic plasma exchange for the treatment of chronic inflammatory demyelinating polyneuropathy. Lieker I; Slowinski T; Harms L; Hahn K; Klehmet J J Clin Apher; 2017 Dec; 32(6):486-493. PubMed ID: 28485075 [TBL] [Abstract][Full Text] [Related]
9. Apheresis treatment in autoimmune neurological diseases: Predictors of good clinical outcome and success of follow-up therapy with B-cell depletion. Fousse M; Fassbender K; Schunk SJ; Schmidt T; Stögbauer J J Neurol Sci; 2024 Jun; 461():123050. PubMed ID: 38768532 [TBL] [Abstract][Full Text] [Related]
10. Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study. Heine J; Ly LT; Lieker I; Slowinski T; Finke C; Prüss H; Harms L J Neurol; 2016 Dec; 263(12):2395-2402. PubMed ID: 27604620 [TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of immunoadsorption versus plasma exchange in steroid-refractory relapse of multiple sclerosis and clinically isolated syndrome: A randomised, parallel-group, controlled trial. Dorst J; Fangerau T; Taranu D; Eichele P; Dreyhaupt J; Michels S; Schuster J; Ludolph AC; Senel M; Tumani H EClinicalMedicine; 2019 Nov; 16():98-106. PubMed ID: 31832624 [TBL] [Abstract][Full Text] [Related]
12. Adverse events of lipoprotein apheresis and immunoadsorption at the Apheresis Center at the University Hospital Dresden. Dittrich-Riediger J; Schatz U; Hohenstein B; Julius U Atheroscler Suppl; 2015 May; 18():45-52. PubMed ID: 25936304 [TBL] [Abstract][Full Text] [Related]
13. [Immunoadsorption for steroid-unresponsive multiple sclerosis-relapses: clinical data of 14 patients]. Mauch E; Zwanzger J; Hettich R; Fassbender C; Klingel R; Heigl F Nervenarzt; 2011 Dec; 82(12):1590-5. PubMed ID: 21667161 [TBL] [Abstract][Full Text] [Related]
14. A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis. Köhler W; Bucka C; Klingel R J Clin Apher; 2011 Dec; 26(6):347-55. PubMed ID: 22095647 [TBL] [Abstract][Full Text] [Related]
16. Removal kinetics of antibodies against glutamic acid decarboxylase by various plasmapheresis modalities in the treatment of neurological disorders. Ohkubo A; Okado T; Kurashima N; Maeda T; Miyamoto S; Nakamura A; Seshima H; Iimori S; Sohara E; Uchida S; Rai T Ther Apher Dial; 2014 Jun; 18(3):231-7. PubMed ID: 24965288 [TBL] [Abstract][Full Text] [Related]
17. Immunoadsorption with regenerating systems in neurological disorders --A single center experience. Hohenstein B; Passauer J; Ziemssen T; Julius U Atheroscler Suppl; 2015 May; 18():119-23. PubMed ID: 25936315 [TBL] [Abstract][Full Text] [Related]